Skip to Content

GP 118 (Mefloquine 250 mg)

Pill imprint GP 118 has been identified as Mefloquine hydrochloride 250 mg.

Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. There is no proven risk in humans during pregnancy. Mefloquine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mefloquine hydrochloride 250 mg GP 118  Front
Mefloquine hydrochloride 250 mg GP 118  Back
Mefloquine hydrochloride 250 mg GP 118
Discount Card Promo
Mefloquine hydrochloride
GP 118
250 mg
Prescription only
Drug Class:
Antimalarial quinolines
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
low substituted hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
corn starch
magnesium silicate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5407 A-S Medication Solutions, LLC (repackager)
54868-5434 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.